Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
A Multicentre, Stratified, Open, Randomized, Comparator-controlled, Parallel-group Phase III Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
A Multicentre, Stratified, Open, Randomized, Comparator-controlled, Parallel-group Phase III Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Status: Enrolling
Updated: 12/31/1969
Cedars Sinai Medical Center Samuel Oschin Cancer Center
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
A Phase 1b/2 Study of Repeat rAdiation, Minocycline, and Bevacizumab in Patients With Recurrent gliOma (RAMBO)
Status: Enrolling
Updated:  12/31/1969
572
mi
from 91732
Salt Lake City, UT
Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
A Phase 1b/2 Study of Repeat rAdiation, Minocycline, and Bevacizumab in Patients With Recurrent gliOma (RAMBO)
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
1784
mi
from 91732
Birmingham, AL
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
99
mi
from 91732
La Jolla, CA
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
99
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
355
mi
from 91732
San Francisco, CA
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
2032
mi
from 91732
Cleveland, OH
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
7513
mi
from 91732
St. Leonards,
A Study in Recurrent Glioblastoma (GB)
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
7513
mi
from 91732
St. Leonards,
Click here to add this to my saved trials
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
356
mi
from 91732
San Francisco, CA
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
345
mi
from 91732
Phoenix, AZ
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Phoenix Children's Hospital
345
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
101
mi
from 91732
San Diego, CA
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Rady Children's Hospital
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2497
mi
from 91732
Hartford, CT
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Hospital
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2185
mi
from 91732
Orlando, FL
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Hospital for Children- MD Anderson
2185
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
819
mi
from 91732
Honolulu, HI
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
819
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1840
mi
from 91732
Grand Rapids, MI
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Helen DeVos Children's Hospital
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1509
mi
from 91732
Minneapolis, MN
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital & Clinics of Minnesota
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1340
mi
from 91732
Kansas City, MO
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospitals and Clinics
1340
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2102
mi
from 91732
Charlotte, NC
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Levine Children's Hospital
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2295
mi
from 91732
Hershey, PA
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center and Children's Hospital
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
2184
mi
from 91732
Charleston, SC
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1762
mi
from 91732
Nashville, TN
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Austin, TX
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Dell Children's Blood and Cancer Center
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1221
mi
from 91732
Dallas, TX
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Texas Children's Cancer and Hematology Centers
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
572
mi
from 91732
Salt Lake City, UT
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Primary Children's Hospital
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated:  12/31/1969
1571
mi
from 91732
Saint Louis, MO
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
1571
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Phase II Trial of Pulse Dosing of Lapatinib in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly-Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
25
mi
from 91732
Los Angeles, CA
Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Phase II Trial of Pulse Dosing of Lapatinib in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly-Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
UCLA
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
15
mi
from 91732
Los Angeles, CA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
356
mi
from 91732
San Francisco, CA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
825
mi
from 91732
Aurora, CO
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Children Hospital of Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
1922
mi
from 91732
Atlanta, GA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
1730
mi
from 91732
Chicago, IL
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
University of Chicago Comer Children's Hospital
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Boston, Dana-Farber Cancer Institute.
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
1932
mi
from 91732
Ann Arbor, MI
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
1880
mi
from 91732
Cincinnati, OH
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
2375
mi
from 91732
Philadelphia, PA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
328
mi
from 91732
Palo Alto, CA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital at Stanford University Medical Center
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
1195
mi
from 91732
Fort Worth, TX
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Cook Children's Medical Center - Fort Worth
1195
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
964
mi
from 91732
Seattle, WA
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Regional Medical Center - Seattle
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated:  12/31/1969
2158
mi
from 91732
Toronto,
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Hospital for Sick Children
2158
mi
from 91732
Toronto,
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
1785
mi
from 91732
Birmingham, AL
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Alabama
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
15
mi
from 91732
Los Angeles, CA
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
352
mi
from 91732
Oakland, CA
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Research Center Oakland
352
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
21
mi
from 91732
Orange, CA
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Orange County
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
328
mi
from 91732
Palo Alto, CA
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital Stanford University
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
2497
mi
from 91732
Hartford, CT
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
2486
mi
from 91732
New Haven, CT
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Yale University
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
2281
mi
from 91732
Washington,
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated:  12/31/1969
2204
mi
from 91732
Fort Myers, FL
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Status: Enrolling
Updated: 12/31/1969
Lee Memorial Health System
2204
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials